Legend Biotech Corp (LEGN)
39.35
-0.83
(-2.07%)
USD |
NASDAQ |
Nov 13, 16:00
39.33
-0.02
(-0.05%)
After-Hours: 20:00
Legend Biotech Price to Book Value: 6.257 for Nov. 13, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 6.257 |
| November 12, 2024 | 6.389 |
| November 11, 2024 | 6.367 |
| November 08, 2024 | 6.365 |
| November 07, 2024 | 6.511 |
| November 06, 2024 | 6.581 |
| November 05, 2024 | 7.095 |
| November 04, 2024 | 6.934 |
| November 01, 2024 | 7.054 |
| October 31, 2024 | 7.158 |
| October 30, 2024 | 7.039 |
| October 29, 2024 | 7.228 |
| October 28, 2024 | 7.203 |
| October 25, 2024 | 7.114 |
| October 24, 2024 | 7.006 |
| October 23, 2024 | 6.988 |
| October 22, 2024 | 7.161 |
| October 21, 2024 | 6.909 |
| October 18, 2024 | 6.817 |
| October 17, 2024 | 6.852 |
| October 16, 2024 | 6.999 |
| October 15, 2024 | 7.141 |
| October 14, 2024 | 7.899 |
| October 11, 2024 | 7.950 |
| October 10, 2024 | 7.992 |
| Date | Value |
|---|---|
| October 09, 2024 | 7.766 |
| October 08, 2024 | 7.642 |
| October 07, 2024 | 7.884 |
| October 04, 2024 | 7.802 |
| October 03, 2024 | 7.599 |
| October 02, 2024 | 7.740 |
| October 01, 2024 | 7.550 |
| September 30, 2024 | 7.748 |
| September 27, 2024 | 7.834 |
| September 26, 2024 | 7.449 |
| September 25, 2024 | 6.925 |
| September 24, 2024 | 7.197 |
| September 23, 2024 | 7.302 |
| September 20, 2024 | 7.717 |
| September 19, 2024 | 8.082 |
| September 18, 2024 | 7.936 |
| September 17, 2024 | 8.136 |
| September 16, 2024 | 8.106 |
| September 13, 2024 | 7.951 |
| September 12, 2024 | 8.016 |
| September 11, 2024 | 7.863 |
| September 10, 2024 | 7.870 |
| September 09, 2024 | 7.959 |
| September 06, 2024 | 7.632 |
| September 05, 2024 | 8.542 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
5.240
Minimum
Mar 04 2021
36.66
Maximum
Oct 11 2021
13.63
Average
10.89
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 5.259 |
| Alnylam Pharmaceuticals Inc | 1054.32 |
| BioCryst Pharmaceuticals Inc | -- |
| Biomarin Pharmaceutical Inc | 2.347 |
| National Healthcare Corp | 2.039 |
Price to Book Value Related Metrics
| PS Ratio | 15.71 |
| Price | 39.35 |
| Earnings Yield | -3.91% |
| Market Cap | 7.252B |